These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications]. Lange CM, Sarrazin C, Zeuzem S. Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084 [No Abstract] [Full Text] [Related]
8. Viral hepatitis C in 2014--the beginning of the end? Prelipcean CC, Gogălniceanu P, Mihai C. Rev Med Chir Soc Med Nat Iasi; 2014 Jan; 118(2):272-8. PubMed ID: 25076687 [No Abstract] [Full Text] [Related]
11. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection. Fernández-Yunquera A, Rincón D, Salcedo M, Bañares R. Rev Esp Quimioter; 2013 Sep; 26(3):189-92. PubMed ID: 24080883 [No Abstract] [Full Text] [Related]
12. Protease inhibitors in hepatitis C: from chronic disease to cure. Iqbal M, McCormick PA. Ir Med J; 2011 Sep; 104(8):230-1. PubMed ID: 22125874 [No Abstract] [Full Text] [Related]
13. New developments in HCV therapy. Kronenberger B, Zeuzem S. J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414 [Abstract] [Full Text] [Related]
14. [Hepatitis C update: what has changed? What can we expect in the near future?]. Geier A. MMW Fortschr Med; 2013 Nov 07; 155(19):59-62. PubMed ID: 24475674 [No Abstract] [Full Text] [Related]
15. Future of hepatitis C therapy: development of direct-acting antivirals. Dore GJ, Matthews GV, Rockstroh J. Curr Opin HIV AIDS; 2011 Nov 07; 6(6):508-13. PubMed ID: 21897228 [Abstract] [Full Text] [Related]